INNVIERTE
The CDTI SICC Innvierte of Innovation invests, together with DRAPER B1 III RCF SMES, ARKADIA SPACE, company dedicated to the development of green propulsion systems
The input committed by the CDTI innovation is eur 360 000
Ver sección
The CDTI Innovation invests, together with NOLABEY GRUP, S.L. VIRTUAL BODYWORKS, S.L., whom he carried out a new proprietary technology KiinX Engine and Embodiment, offering training experiences immersive applications
The input committed by the CDTI innovation is €500,000
Ver sección
In february Innvierte allocates more than 240 million euros to five new coinversiones and three investment vehicles
These operations are aimed at various developments of the sectors embraced, Bio, health and agri-food Industry, ict, energy and Environment
Ver sección
The Innovation and CDTI Suma Capital invested in WATTWIN, the platform which digitizes the sales of photovoltaic project
The input committed by the CDTI Innovation amounts to €540,000
Ver sección
The CDTI Innovation fund invests in Impact Bridge Sustainable AgriFood Fund I Innvierte, to support smes in their food growth and transition to a more sustainable model
The objective of the CDTI Innovation with this operation is to support the capitalization of innovative technology companies
Ver sección
In january Innvierte allocates more than €1 million to two new coinversiones in risk capital
Since january 2025 the CDTI Innovation through Innvierte has closed operations, joint investment in 2 companies with a commitment 1.13 million euros
Ver sección
The CDTI Innovation invests, together with SABADELL ASABYS HEALTH INNOVATION INVESTMENTS II, RCF and SABADELL ASABYS HEALTH INNOVATION INVESTMENTS 2B, SCR SA, QUIBIM, S.L., company biomedical technology
The input committed by the CDTI innovation is eur 2,500,000
Ver sección
El CDTI Innovación invierte en la empresa estratégica ONCOMATRYX BIOPHARMA S.L., pionera en el desarrollo de fármacos contra el microambiente tumoral
The input committed by the CDTI innovation is eur 10,000,000
Ver sección
El CDTI Innovación invierte, junto con INVEREADY BIOTECH IV S.C.R, S.A, INVEREADY BIOTECH IV PARELLEL S.C.R., S.A, e INVEREADY INNVIERTE CONVERTIBLE TECH NOTES I S.C.R, S.A., en GENIOVA TECHNOLOGIES S.L
The input committed by the CDTI innovation is eur 3.6 million
Ver sección
Subscribe to INNVIERTE